Postoperative venous thromboembolism event increases risk of readmissions and reoperation following total joint arthroplasty: a propensity-matched cohort study

[1]  R. Schwarzkopf,et al.  Tranexamic Acid Is Safe in Patients with a History of Coronary Artery Disease Undergoing Total Joint Arthroplasty , 2021, The Journal of bone and joint surgery. American volume.

[2]  C. Sicat,et al.  Aspirin Use for Venous Thromboembolism Prevention Is Safe and Effective in Overweight and Obese Patients Undergoing Revision Total Hip and Knee Arthroplasty. , 2020, The Journal of arthroplasty.

[3]  J. Slover,et al.  Discontinued Use of Outpatient Portable Intermittent Pneumatic Compression Devices May Be Safe for Venous Thromboembolism Prophylaxis in Primary Total Knee Arthroplasty Using Low-Dose Aspirin , 2020, The Journal of Knee Surgery.

[4]  K. Bennell,et al.  Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study , 2020, Annals of the Rheumatic Diseases.

[5]  J. Bosco,et al.  Low-Dose Aspirin is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Knee Arthroplasty: A Retrospective Cohort Study , 2020, The Journal of Knee Surgery.

[6]  J. Bosco,et al.  Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Hip Arthroplasty: A Retrospective Cohort Study. , 2020, The Journal of arthroplasty.

[7]  B. Lindsey,et al.  Portable compression devices in total joint arthroplasty: poor outpatient compliance , 2020, Arthroplasty today.

[8]  M. Whitehouse,et al.  Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials. , 2020, JAMA internal medicine.

[9]  M. Abola,et al.  The Incremental Cost of Inpatient Venous Thromboembolism following Hip Fracture Surgery. , 2020, Journal of orthopaedic trauma.

[10]  A. Vaccaro,et al.  Propensity Score Matching: A Statistical Method. , 2020, Clinical spine surgery.

[11]  W. Barsoum,et al.  No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA , 2019, Clinical orthopaedics and related research.

[12]  A. Benditz,et al.  Revision Surgery in Total Joint Replacement Is Cost-Intensive , 2018, BioMed research international.

[13]  W. Barsoum,et al.  Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty. , 2018, The Journal of arthroplasty.

[14]  A. Siddiqi,et al.  Routine Preoperative Venous Doppler Screening Is Not Effective in Preventing Thromboembolic Events After Total Joint Arthroplasty. , 2018, Orthopedics.

[15]  J. Hansen,et al.  Acute infection as a trigger for incident venous thromboembolism: Results from a population‐based case‐crossover study , 2017, Research and practice in thrombosis and haemostasis.

[16]  Rahmi Oklu,et al.  Deep vein thrombosis: pathogenesis, diagnosis, and medical management. , 2017, Cardiovascular diagnosis and therapy.

[17]  N. Heckmann,et al.  Venous Thromboembolism Prophylaxis in Total Hip Arthroplasty and Total Knee Arthroplasty Patients: From Guidelines to Practice. , 2017, The Journal of the American Academy of Orthopaedic Surgeons.

[18]  D. Beverland,et al.  Venous Thromboembolism Following Hip and Knee Arthroplasty: The Role of Aspirin. , 2017, The Journal of bone and joint surgery. American volume.

[19]  J. Parvizi,et al.  The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States. , 2017, The Journal of arthroplasty.

[20]  Zong-ke Zhou,et al.  Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years , 2015, BMC Musculoskeletal Disorders.

[21]  W. Hamilton,et al.  Patient satisfaction with mobile compression devices following total hip arthroplasty. , 2014, Orthopedics.

[22]  J. Berlin,et al.  Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty , 2014, Vascular health and risk management.

[23]  R. Seaton,et al.  Risk of venous thromboembolism in patients treated for bacterial infection in the community with outpatient parenteral antimicrobial therapy. , 2014, QJM : monthly journal of the Association of Physicians.

[24]  D. Giannarelli,et al.  Prevention of VTE in orthopedic surgery patients , 2013 .

[25]  W. Olson,et al.  In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty , 2012, Journal of medical economics.

[26]  Yngve Falck-Ytter,et al.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[27]  L. Smeeth,et al.  Acute infections and venous thromboembolism , 2011, Journal of internal medicine.

[28]  O. Baser.  Prevalence and economic burden of venous thromboembolism after total hip arthroplasty or total knee arthroplasty. , 2011, The American journal of managed care.

[29]  O. Baser,et al.  Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery , 2011, Current medical research and opinion.

[30]  A. Ruppert,et al.  Economic burden of venous thromboembolism: a systematic review , 2011, Journal of medical economics.

[31]  J. West,et al.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study , 2010, The Lancet.

[32]  P. Jolliet,et al.  Immobilization and the risk of venous thromboembolism. A meta-analysis on epidemiological studies. , 2009, Thrombosis research.

[33]  Peter C Austin,et al.  Some Methods of Propensity‐Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations , 2009, Biometrical journal. Biometrische Zeitschrift.

[34]  Clifford W Colwell,et al.  Prevention of Venous Thromboembolism* American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition) , 2008 .

[35]  Marco Caliendo,et al.  Some Practical Guidance for the Implementation of Propensity Score Matching , 2005, SSRN Electronic Journal.

[36]  B. Zicat,et al.  The prevalence of venous thromboembolism after hip and knee replacement surgery , 2005, The Medical journal of Australia.

[37]  Samuel Z Goldhaber,et al.  Prevention of venous thromboembolism among hospitalized medical patients. , 2005, Circulation.

[38]  G. Oster,et al.  Economic Consequences of Venous Thromboembolism Following Major Orthopedic Surgery , 2004, The Annals of pharmacotherapy.

[39]  L. Melton,et al.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. , 2002, Archives of internal medicine.

[40]  H. Büller,et al.  Deep vein thrombosis and pulmonary embolism , 1993, The Lancet.

[41]  I Iturralde,et al.  Deep vein thrombosis and pulmonary embolism , 1990 .

[42]  G. Raskob,et al.  The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. , 2016, Thrombosis research.

[43]  C. Turkelson,et al.  Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. , 2011, The Journal of the American Academy of Orthopaedic Surgeons.

[44]  C. Pashos,et al.  Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.